PMEL and melanoma: While all vaccines induced a significant increase of TRP1-, Tyr-, gp100-, and MART1-specific T cells in TILs in comparison to PBS-injected mice (Fig. 4A), the frequency of melanoma-specific T cells was highest in DC-shA20-FAP-TRP2 vaccinated mice (p<0.05).